The US Food and Drug Administration is advising doctors to consider alternatives to pain reliever Celebrex in the wake of a study that showed it increased the risk of heart attack and strokes at high doses. 

Pfizer Inc. said on Friday that it would leave Celebrex on the market, although the same problems led Merck & Co. to withdraw its painkiller Vioxx from the market in September.

Were leaving open all regulatory decisions as we move forward. But we do not have a decision on the fate of the product, Acting FDA Commissioner Lester Crawford said Friday.

We do have great concern about this product (Celebrex) and the class of products. Crawford said doctors should think about other types of drugs to help patients relieve pain.

Doctors said they were already inundated with calls from nervous patients and were pledging to curtail their use of the drug. The disclosure sent Pfizers stock tumbling yesterday amid fears it would cripple sales of what had been the most-prescribed drug for treating arthritis.

Shares of Pfizer, the worlds largest pharmaceutical maker, plunged $3.23 (euro2.43), to close at $25.75 (euro19.38) on the New York Stock Exchange. The decline wiped out almost $25 billion (euro19 billion) of Pfizers market value.

Both Celebrex and Vioxx are a type of drug called cox-2 inhibitors. Vioxx was pulled from the market in September because it doubled patients risk of heart attack and stroke.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Bextra, Celebrex MDL judge sets first Bextra trial

On the heels of the $4.85 Billion Vioxx settlement, the Multi-District Litigation (MDL) Court for the...

End Conflicts on FDA Approvals

In the coming weeks, the U.S. House and Senate will have to reconcile bills they passed that give the...

Frank Woodson on the Additional Costs and Hidden...

Frank Woodson and David Miceli discuss the additional costs and hidden dangers associated with COX-2...

Cox-2 Inhibitors

What are Cox-2 inhibitors? Our law firm has been in the forefront of the effort to have all of the...

Celebrex

What is Celebrex? Celebrex is in a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs)....

Wrongful Death Suit Filed Against Drug Company

A wrongful death lawsuit was filed Monday in Tuscaloosa County against a drug company that makes and...

Best for clients

Great firm. Supports the community. They want what is best for their clients.

—Jennifer